American biotechnology firm Regeneron Pharmaceuticals is buying the personal genetics brand 23andMe after submitting a winning bid of $256 million in a bankruptcy auction, according to a Monday ...

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...

Dow Jones Top Company Headlines at 11 AM ET: Home Depot Plans to Keep Prices Steady Despite Tariffs | BMW ... The retailer has been pushing suppliers to shift production out of China and keep prices ...

Bay Area News Group: Live Organ Donations Are Growing In The U.S., California And Bay Area, But So Is The Need Since 2014, more than 500,000 people in the U.S. have donated organs, 200,000 of ...

Regeneron Pharmaceuticals REGN has emerged as the successful bidder in the bankruptcy auction for most of the assets of ...

The bankrupt genetic-testing firm will hand over its entire data bank, including DNA samples of around 15 million people. Regeneron has said it will abide by 23andMe’s privacy policy, allowing ...

It is now illegal to publish or threaten to publish real or AI-generated intimate images of a person without their consent. Tech sites and companies also must take down such images within 48 hours of ...

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...

The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...

Regeneron acquires 23andMe for $256 million following its bankruptcy. The deal includes DNA data access, raising privacy ...

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.